Clinical Trial: Construction and Validation of a Deep Learning-Based Pathological Diagnostic Scoring System for Acral Melanocytic Tumors and Evaluation of Its Clinical Assistance Performance (China)

Posted On: 2026-09-25

China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction and Validation of a Deep Learning-Based Pathological Diagnostic Scoring System for Acral Melanocytic Tumors and Evaluation of Its Clinical Assistance Performance'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133317

Registration Time: 2026/09/24

Type: Observational study

Primary Sponsor: Chinese PLA General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332673

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Construction and Validation of a Deep Learning-Based Pathological Diagnostic Scoring System for Acral Melanocytic Tumors and Evaluation of Its Clinical Assistance Performance (China)